巨肌钙蛋白对两种高敏心肌肌钙蛋白检测第99百分位阈值的影响
本研究基于丹麦健康人群的1058份血浆样本,评估巨肌钙蛋白对两种高敏心肌肌钙蛋白检测第99百分位的影响。采用IgG去除筛查和蔗糖梯度法确认巨肌钙蛋白,发现Siemens样本中76%阳性而Roche样本均阴性。排除巨肌钙蛋白后,Siemens第99百分位男性从117 ng/L降至22 ng/L,女性从37 ng/L降至9 ng/L。
要点
- Siemens高敏肌钙蛋白I检测中巨肌钙蛋白阳性率达76%,Roche高敏肌钙蛋白T检测未发现阳性。
- 排除巨肌钙蛋白后Siemens第99百分位显著降低,男性117→22 ng/L,女性37→9 ng/L。
- 第99/50百分位比值可从12-29倍降至3-7倍,接近Roche比值,或有助于评估巨肌钙蛋白干扰。
核心结论
- 巨肌钙蛋白显著影响Siemens Atellica高敏肌钙蛋白I的第99百分位阈值,提示重要临床意义,需进一步前瞻性研究。
- 第99/50百分位比值可能有助于评估肌钙蛋白检测中的巨肌钙蛋白干扰。
研究设计与样本
- 研究分析了1058份健康个体血浆样本,这些样本此前用于建立丹麦肌钙蛋白第99百分位。
- 依据国际临床化学与实验室医学联合会教育建议,对肌钙蛋白水平前10%的样本采用IgG去除筛查和蔗糖梯度参考方法评估巨肌钙蛋白,两种方法一致时确认阳性。
- 因分析稀释限制,135份Siemens Atellica高敏肌钙蛋白I样本中最高88份用两种方法分析;所有106份Roche高敏肌钙蛋白T样本经IgG去除均为阴性,蔗糖分析仅限最高70份。
主要发现
- Siemens样本中巨肌钙蛋白阳性率为76%(67/88),Roche样本中为0%(0/70)。
- 排除巨肌钙蛋白影响样本后,Siemens第99百分位男性从117 ng/L降至22 ng/L,女性从37 ng/L降至9 ng/L。
- Siemens第99/50百分位比值从12-29倍降至3-7倍,接近Roche比值。
关键数值与推荐
- Siemens高敏肌钙蛋白I第99百分位男性117 ng/L,女性37 ng/L;排除巨肌钙蛋白后男性22 ng/L,女性9 ng/L。
- Siemens第99/50百分位比值从12-29倍降至3-7倍。
临床怎么用
- 检验科应关注巨肌钙蛋白对高敏肌钙蛋白检测第99百分位的干扰,尤其在使用Siemens Atellica检测时。
- 第99/50百分位比值可作为评估巨肌钙蛋白干扰的辅助指标。
局限性
- 研究仅分析了最高10%肌钙蛋白水平的样本,可能未全面反映巨肌钙蛋白在全部范围内的频率。
- Siemens样本因分析稀释限制仅分析了最高88份,Roche蔗糖分析仅限最高70份。
- 研究为回顾性分析,临床影响需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac troponin (cTn) levels exceeding the 99th percentile upper reference limit and a rise/fall pattern are key for diagnosing myocardial injury and infarction. Macrotroponins, formed by patient anti-cTn antibodies targeting cTn, can cause persistently elevated cTn levels without ongoing myocardial injury. The frequency and impact of macrotroponin interference on cTn 99th percentiles are unclear. This study compares sex-specific 99th percentiles for 2 cTn assays, before and after excluding macrotroponin-positive samples, focusing on the top 10% of cTn levels. METHODS: We examined 1058 plasma samples from healthy individuals previously used for Danish cTn 99th percentiles. Following International Federation of Clinical Chemistry and Laboratory Medicine educational recommendations, macrotroponin presence was assessed in the top 10% cTn samples using immunoglobulin G (IgG) depletion screening and a reference sucrose gradient, confirming macrotroponin when both methods concurred. Due to analytical dilution constraints, [the highest] 88 of 135 Siemens Atellica high-sensitivity cTnI (hs-cTnI) samples were analyzed with both methods. All 106 Roche hs-cTnT samples were negative using IgG depletion, and sucrose analysis was limited to the highest 70 samples. RESULTS: Macrotroponin was found in 76% (67/88) of Siemens samples but in none of the Roche samples (0/70). Excluding macrotroponin-affected samples lowered the Siemens 99th percentiles from 117 ng/L to 22 ng/L in men and from 37 ng/L to 9 ng/L in women. The 99th/50th percentile ratio for Siemens decreased from 12- to 29-fold to 3- to 7-fold, approaching the Roche ratios. CONCLUSIONS: Macrotroponin significantly influenced the Siemens Atellica hs-cTnI 99th percentiles, suggesting important clinical implications that warrant further prospective studies. The 99th/50th percentile ratio may help evaluate macrotroponin interference in troponin assays.
引用
- Strandkjær N, Hansen MB, Afzal S, et al. Influence of Macrotroponin on the 99th Percentile Threshold in 2 High-Sensitivity Cardiac Troponin Assays. Clin Chem. 2025. PMID: 40492538. doi:10.1093/clinchem/hvaf068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。